Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP562395.RArs1iD8afqCQ-_BJw9PZmfSEH2fPszgEOx-xDumMjrOA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP562395.RArs1iD8afqCQ-_BJw9PZmfSEH2fPszgEOx-xDumMjrOA130_assertion type Assertion NP562395.RArs1iD8afqCQ-_BJw9PZmfSEH2fPszgEOx-xDumMjrOA130_head.
- NP562395.RArs1iD8afqCQ-_BJw9PZmfSEH2fPszgEOx-xDumMjrOA130_assertion description "[The iv administration of Gd-DOTAMA-C6-Gln allowed the MRI visualization of tumor masses in A/J mice grafted with the murine neuroblastoma cell line Neuro-2a and in Her-2/neu transgenic mice developing multiple mammary carcinoma, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562395.RArs1iD8afqCQ-_BJw9PZmfSEH2fPszgEOx-xDumMjrOA130_provenance.
- NP562395.RArs1iD8afqCQ-_BJw9PZmfSEH2fPszgEOx-xDumMjrOA130_assertion evidence source_evidence_literature NP562395.RArs1iD8afqCQ-_BJw9PZmfSEH2fPszgEOx-xDumMjrOA130_provenance.
- NP562395.RArs1iD8afqCQ-_BJw9PZmfSEH2fPszgEOx-xDumMjrOA130_assertion SIO_000772 16884304 NP562395.RArs1iD8afqCQ-_BJw9PZmfSEH2fPszgEOx-xDumMjrOA130_provenance.
- NP562395.RArs1iD8afqCQ-_BJw9PZmfSEH2fPszgEOx-xDumMjrOA130_assertion wasDerivedFrom befree-2016 NP562395.RArs1iD8afqCQ-_BJw9PZmfSEH2fPszgEOx-xDumMjrOA130_provenance.
- NP562395.RArs1iD8afqCQ-_BJw9PZmfSEH2fPszgEOx-xDumMjrOA130_assertion wasGeneratedBy ECO_0000203 NP562395.RArs1iD8afqCQ-_BJw9PZmfSEH2fPszgEOx-xDumMjrOA130_provenance.